ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 62 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 5,292,156 | $3,281,000 | 0.46% |
Northeast Financial Consultants Inc | 577,262 | $358,000 | 0.05% |
Founders Capital Management | 7,000 | $4,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 186,254 | $115,000 | 0.00% |
A.R.T. Advisors, LLC | 13,455 | $8,000 | 0.00% |
WILLIAMS JONES & ASSOCIATES LLC | 30,100 | $19,000 | 0.00% |
Creative Planning | 200,189 | $124,000 | 0.00% |
GLENMEDE TRUST CO NA | 4 | $0 | 0.00% |
IFP Advisors, Inc | 1,518 | $1,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 1,552 | $962,000 | 0.00% |